Cancer treatments and one titin variant: multiple hits to the heart

20 June 2026 (14:39 - 14:48)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Michela Schenone

Genova (Italy)

4 More presentations in this session

Presentation thumbnail

Cardio-oncology–guided modification of breast cancer therapy in a patient with stage C heart failure with mildly reduced ejection fraction

Doctor G. Bayshtok (New York, US)

Presentation thumbnail

Beyond ejection fraction: managing HER2 positive breast cancer in a patient with severe mitral regurgitation and prior anthracyclines

Doctor B. Andrade (Santarem, PT)

Presentation thumbnail

Multimodal diagnosis and management strategy in chemo- and radiotherapy-induced complex cardiomyopathy

Doctor A. Sharma (Dallas, US)

Presentation thumbnail

Racing against time: multidisciplinary management of acute anthracycline-induced cardiotoxicity

Doctor C. Regragui (Paris, FR)

Access the full session

Session thumbnail

The road to heart failure: untold stories

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 14:39 CET

You may be interested in

Congress Session

Recent perspectives in cardio-oncology

17 May 2025

Congress Presentation

Targeting titin in dilated cardiomyopathy

1 September 2024

Congress Presentation

Cancer therapeutics-related heart failure from a cohort study using big data of electronic health record in japan.

2 September 2019

Congress Presentation

Exercise may lower risk of cancer therapy-related cardiac dysfunction (CTRCD) in early-stage breast cancer patients undergoing targeted therapy. Results from a small prospective study.

21 June 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources